Medicine News

Angiotech Pharmaceuticals And Partner Athersys Announce Positive Results From Phase I St ...
Thu, 29 July 2010
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) (Angiotech) and partner Athersys, Inc. (NASDAQ: ATHX) announced positive results from its phase I clinical trial of MultiStem(R), its allogeneic cell therapy product, administered to individuals following acute myocardial infarction (AMI), more commonly referred to as ...
Advanced Life Sciences Applies For FDA Fast-Track Designation For Restanza In CABP
Thu, 29 July 2010
Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced that the Company has applied to the U.S...
Abbott's SIMCOR ( Niacin Extended-release / Simvastatin ) Receives FDA Approval For New ...
Thu, 29 July 2010
Abbott (NYSE: ABT) received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCOR, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin the most commonly prescribed dose of simvastatin with either 500 mg or 1,000 mg of niacin extended-release...
Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial Of PSI-938 In Patie ...
Thu, 29 July 2010
Pharmasset, Inc. (Nasdaq: VRUS) announced that safety and pharmacokinetic data from the PSI-352938 (PSI-938) single ascending dose study support progression to a multiple ascending dose trial with PSI-938, which has initiated dosing. PSI-938 is a guanine nucleotide analog polymerase inhibitor for the treatment of chronic he ...
Topaz Pharmaceuticals Announces Positive Data From Topical Ivermectin Trials Presented A ...
Thu, 29 July 2010
Topaz Pharmaceuticals Inc., a privately held biotechnology company, announced positive results of studies of topical ivermectin cream, which it is developing as a potential treatment of Pediculus humanus capitis (head lice)...
Chimerix's CMX157 Shows Potential To Treat Multi-Drug-Resistant HIV And Improve The Acti ...
Thu, 29 July 2010
Chimerix, Inc...
New England Journal Of Medicine Publishes Data From Pivotal Phase 3 PROVENGE IMPACT Study
Thu, 29 July 2010
Dendreon Corporation (Nasdaq: DNDN) announced the publication of data from the pivotal Phase 3 IMPACT study in the New England Journal of Medicine, showing that PROVENGE (sipuleucel-T) demonstrated a statistically significant improvement in overall survival compared to control in men with asymptomatic or minimally symptomati ...
New Tool For Accessing Bioinformatics Resources
Thu, 29 July 2010
Developed by researchers at the UPM's Facultad de Informática, this tool can discover and automatically classify bioinformatics resources from the scientific literature. Bioinformatics resources have proliferated in the years since the end of the Human Genome Project, obliging researchers to spend a quite a lot of time brow ...
Advanced Biofuel Trade Associations Express Support For Tax Policy On Second-Generation ...
Wed, 28 July 2010
As Congress takes action on critical tax incentive packages, the leading advanced biofuel trade associations reemphasized the importance of advanced biofuels as promising opportunities for the United States to reduce its reliance on oil and create green jobs. Sustained and diverse federal programs, including tax incentives, ...
New Study Reveals UK Patients Are Less Likely To Receive Innovative Medicines
Wed, 28 July 2010
One of the most comprehensive reports comparing the use of medicines in the UK with that in other countries has been published by the Department of Health. The report shows that the UK still lags behind comparable countries in Europe and elsewhere on its use of newer cancer treatments and medicines for chronic diseases such ...

News

This section contains news related to the medicine industry.

Publishers of medicine related news can register for free on our website and add their medicine news to this website.

Our websites

Chemicals 1.com

GMP 1.com

Laboratory Supplies 1.com

Medical Products 1.com

Pharmaceuticals 1.com

Veterinary Products 1.com

More 1.com websites...

- About us
- About Medicines 1.com
- Email us
- Terms of use
- Using Medicines 1.com
- Register (free) / Join now
- Memberships
- How to buy/sell
- FAQ / Help

Medicine News - Medicines 1.com

Members in

Algeria
Angola
Benin
Botswana
Burundi
Cameroon
Cote d Ivoire
Djibouti
Ethiopia
Ghana
Guinea
Kenya
Liberia
Libyan Arab Jamahiriya
Malawi
Maldives
Mali
Mauritania
Mauritius
Morocco
Mozambique
Namibia
Niger
Nigeria
Senegal
Sierra Leone
Somalia
South Africa
Sudan
Tanzania, United Republic of
Togo
Tunisia
Uganda
Zaire
Zambia
Zimbabwe
Afghanistan
Bangladesh
Bermuda
Brunei Darussalam
Cambodia
China
Hong Kong
India
Indonesia
Japan
Kazakhstan
Kyrgyzstan
Malaysia
Mongolia
Myanmar
Nepal
Pakistan
Papua New Guinea
Philippines
Singapore
South Korea
Sri Lanka
Taiwan
Tajikistan
Thailand
Viet Nam
Albania
Armenia
Austria
Azerbaijan
Belarus
Belgium
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Georgia
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Macedonia
Malta
Moldova,Republic of
Netherlands (Holland)
Norway
Poland
Portugal
Republic of Serbia
Romania
Russian Federation
San Marino
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
Ukraine
United Kingdom
Uzbekistan
Vatican City State (Holy See)
Yugoslavia
Bahrain
Egypt
Iran
Iraq
Israel
Jordan
Kuwait
Lebanon
Oman
Qatar
Saudi Arabia
Swaziland
Syrian Arab Republic
United Arab Emirates
Yemen
Antigua and Barbuda
Aruba
Bahamas
Barbados
Belize
Canada
Costa Rica
Cuba
Dominican Republic
El Salvador
Guatemala
Haiti
Honduras
Jamaica
Mexico
Netherlands Antilles
Nicaragua
Panama
Puerto Rico
Trinidad and Tobago
United States
Australia
Fiji
New Zealand
Saint Vincent and the Grenadines
Argentina
Bolivia
Brazil
Chile
Colombia
Ecuador
Paraguay
Peru
Suriname
Uruguay
Venezuela
American Samoa
Equatorial Guinea
Lesotho
Grenada

Medicine News

News

Advertisements